Article
Pharmacology & Pharmacy
Stephen Daniels, Mostafa El Mansari, Rami Hamoudeh, Pierre Blier
Summary: Ketamine exerts its antidepressant effects by modulating neuronal activity, enhancing dopamine neuronal activity and normalizing norepinephrine neuronal activity in the locus coeruleus and ventral tegmental area.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Clinical Neurology
Chidiebere M. Iro, Rami Hamati, Mostafa El Mansari, Pierre Blier
Summary: The firing activity of monoamine neurons did not change 1 day after a single ketamine injection, but showed robust increases in NE neurons and enhancement in DA neurons after repeated administration. The increased activity of NE neurons was no longer present 3 days after the last injection, while that of DA neurons remained. This suggests that the enhanced activity of NE and DA neurons may play a significant role in maintaining the antidepressant action of ketamine.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
(2021)
Article
Neurosciences
Pierre Lecouflet, Candice M. Roux, Brigitte Potier, Marianne Leger, Elie Brunet, Jean-Marie Billard, Pascale Schumann-Bard, Thomas Freret
Summary: Activation of the 5-HT4R has been shown to impact LTP within the hippocampal CA1 area through modulation of GABAergic neurotransmission. The study also revealed the involvement of GABA(B) receptor in this regulatory process.
Article
Clinical Neurology
Mostafa El Mansari, Rami Hamoudeh, Stephen Daniels, Pierre Blier
Summary: The present study found decreased firing activity of 5-HT neurons, enhanced burst activity of NE neurons, and reduced sensitivity of the alpha(2)-adrenoceptor in the hippocampus of WKY rats. These findings suggest abnormal neurotransmitter activity in WKY rats.
JOURNAL OF PSYCHOPHARMACOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Caroline Lahogue, Jean-Marie Billard, Thomas Freret, Valentine Bouet
Summary: The 5-HT6 receptors antagonist SB-271046 increases excitatory synaptic transmission and NMDAR activation at the CA3/CA1 hippocampal connections in mice. In male mice, this improvement is related to GABAAR antagonism, while in female mice it is not. Furthermore, the 5-HT6 receptors blockade has no significant effect on synaptic plasticity.
Article
Psychiatry
Bradley A. Fritz, Nicolas Hoertel, Eric J. Lenze, Farid Jalali, Angela M. Reiersen
Summary: Antidepressant exposure is associated with a reduced incidence of emergency department visitation or hospital admission among SARS-CoV-2 positive patients, in a dose-dependent manner. These data support the FIASMA model of antidepressants' effects against COVID-19.
TRANSLATIONAL PSYCHIATRY
(2022)
Article
Neurosciences
Kanza M. Khan, Nagalakshmi Balasubramanian, Gabriel Gaudencio, Ruixiang Wang, Govindhasamy Pushpavathi Selvakumar, Louis Kolling, Samantha Pierson, Satya M. Tadinada, Ted Abel, Marco Hefti, Catherine A. Marcinkiewcz
Summary: Alzheimer's disease (AD) affects over 6 million Americans and presents with mood and sleep changes in the early stages. This study evaluated depressive and anxiety-like behaviors in a mouse model of AD and found a correlation with tau pathology, neuroinflammation, and monoaminergic dysregulation. The results suggest that tau pathology in brainstem monoaminergic nuclei may underpin the behavioral changes observed in the early stages of AD.
ACTA NEUROPATHOLOGICA COMMUNICATIONS
(2023)
Article
Psychiatry
Ivo H. Cerda, Paul J. Fitzgerald
Summary: The article presents a neurochemical model of unipolar major depressive disorder and predicts optimal pharmacological treatment based on different subtypes of depression. It suggests using different medications for high and low NE/5HT depression, and predicts the effects of rapidly acting antidepressants on different subtypes.
PSYCHIATRY RESEARCH
(2021)
Article
Neurosciences
Danilo Benette Marques, Rafael Naime Ruggiero, Lezio Soares Bueno-Junior, Matheus Teixeira Rossignoli, Joao Pereira Leite
Summary: The perception of control over a stressful experience may determine its impacts and generate resistance against future stressors. The study on male rats suggests that hippocampal-prefrontal network theta activity supports cognitive mechanisms of stress coping and is associated with escape performance and vulnerability to stress-related disorders.
JOURNAL OF NEUROSCIENCE
(2022)
Article
Biochemistry & Molecular Biology
Danielle M. Diniz, Francesca Calabrese, Paola Brivio, Marco A. Riva, Joanes Grandjean, Judith R. Homberg
Summary: BDNF plays a crucial role in neuroplasticity, vulnerability and resilience to stress-related disorders. Modulation of BDNF levels in the ventral hippocampus of SERT-/- rats led to positive behavioral outcomes, suggesting BDNF upregulation as a potential target for new therapeutic approaches in improving depressive symptoms.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Biochemistry & Molecular Biology
Daniil Grinchii, Marius C. Hoener, Talah Khoury, Roman Dekhtiarenko, Reyhaneh Nejati Bervanlou, Daniela Jezova, Eliyahu Dremencov
Summary: Trace amine-associated receptor 1 (TAAR1) has been identified as a potential target for future antidepressant, antipsychotic, and anti-addiction drugs. Studies have shown that TAAR1 agonists can produce antidepressant, antipsychotic, and anti-addiction behavioral effects in rodents and primates, and these effects are associated with the modulation of serotonin (5-HT) and dopamine.
MOLECULAR PSYCHIATRY
(2022)
Article
Behavioral Sciences
Qi Wang, Ya-Nan Sun, Chun-Ming Zou, Te-Li Zhang, Zhu Li, Min Liu, Bi-Ying Shi, Shan-Shan Shi, Chun-Yue Yu, Tai-Ming Wei
Summary: The study found that berberine can exert antidepressant effects in a mouse model of depression by modulating factors in the KYN/5-HT pathway. This research is of great significance for understanding the antidepressant mechanism of berberine and developing related drugs.
BEHAVIOURAL BRAIN RESEARCH
(2022)
Review
Medicine, General & Internal
Agoston Patthy, Janos Murai, Janos Hanics, Anna Pinter, Peter Zahola, Tomas G. M. Hokfelt, Tibor Harkany, Alan Alpar
Summary: Alzheimer's disease (AD) is a devastating neurodegenerative disorder for which an effective therapy has yet to be found. Research suggests that early damage to the ascending monoaminergic system in the brainstem may be an early sign and potential trigger of AD. In addition, cortical malfunction and local neurohistopathology are also related to the progression of AD.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Neurosciences
Lindsay J. Agostinelli, Scott C. Seaman, Clifford B. Saper, Dustin P. Fykstra, Marco M. Hefti, Timothy R. Koscik, Brian J. Dlouhy, Alexander G. Bassuk
Summary: Researchers report a study that combines high-resolution MRI and detailed histology to study the impact of neurologic disease on specific cell groups in the human brainstem and cerebellum. These findings are crucial for understanding and diagnosing brainstem lesions.
JOURNAL OF NEUROSCIENCE
(2023)
Review
Neurosciences
Cooper D. Grossman, Jeremiah Y. Cohen
Summary: This article discusses the evolution of nervous systems to adapt to the dynamics of the environment and explains this process through the study of learning and decision-making. The article focuses on the slow dynamics of neuronal networks and the role of neuromodulators in temporal scaling.
ANNUAL REVIEW OF NEUROSCIENCE
(2022)